Aminophylline injection shortage due to end Oct 29
Omega Laboratories reports its aminophylline 25 mg/mL intravenous solution (DIN 00582662) remains in a Tier 3 critical shortage after a manufacturing disruption. The shortage began May 4, 2026 and is expected to end Oct 29, 2026; the company notes a Tier 3 substitute product is available.
Aminophylline is used in acute asthma and COPD care — check the substitute product and stock before the shortage ends.
Shortage expected to end: Oct 29, 2026 All deadlines
Read the original
Official source: Aminophylline injection shortage due to end Oct 29 (opens in a new tab) — Health Product Shortages Canada
